Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/12/2013 06/13/2013 06/14/2013 06/17/2013 06/18/2013 Date
18.02(c) 18.11(c) 18.07(c) 17.81(c) 17.785 Last
2 325 034 1 061 277 2 322 065 863 404 814 767 Volume
-4.86% +0.50% -0.22% -1.44% -0.14% Change
More quotes
Company
Surperformance© rating of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More about the company
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 55,4 M
EBIT 2013 -304 M
Net income 2013 -304 M
Finance 2013 148 M
Yield 2013 -
Sales 2014 164 M
EBIT 2014 -243 M
Net income 2014 -238 M
Finance 2014 110 M
Yield 2014 -
PER 2013 -
PER 2014
EV / Sales 2013 56,7x
EV / Sales 2014 19,3x
Capitalization 3 289 M
More Financials
Latest news on ARIAD PHARMACEUTICALS, INC
3h ago ARIAD PHARMACEUTICALS, INC.: ARIAD Honored with Gold Stevie® Awards as Pharmace..
5d ago ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Webcast of Its Annual Shareholders..
06/11 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Initiation of Phase 2 Trial of Pon..
06/04 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at Upcoming Investor Conferences
06/02 ARIAD PHARMACEUTICALS, INC.: ARIAD Presents Updated Phase 1 Data on AP26113 in ..
06/02 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Long-Term Durability-of-Response D..
06/01 ARIAD PHARMACEUTICALS, INC.: ARIAD Presents Analysis of Cardiovascular Risk Pro..
05/31 ARIAD PHARMACEUTICALS, INC.: Wall Street Fundamentals Releases New In-Depth Sto..
05/30 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the Jefferies 2013 Global Heal..
05/23 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at the Deutsche Bank 38th Annual ..
05/15 ARIAD PHARMACEUTICALS, INC.: ARIAD Announces Data Presentations and Webcast of ..
05/13 ARIAD PHARMACEUTICALS, INC.: ARIAD to Present at UBS Global Healthcare Conferen..
More news
Forum ARIAD PHARMACEUTICALS, INC
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
Ariad Pharmaceuticals, Inc : Income Statement Evolution
More Financials
EPS Revisions
Ariad Pharmaceuticals, Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.